What's in Tanabe Pharma America, Inc.'s pipeline?

Tanabe Pharma America, Inc. has 7 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 0 in Phase 2, 4 in Phase 1.

Which companies overlap with Tanabe Pharma America, Inc.'s portfolio?

Top competitors by shared drug class: AstraZeneca.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/tanabe-pharma-america-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Tanabe Pharma America, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tanabe Pharma America, Inc. pipeline: 0 marketed, 0 filed, 3 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 0 Phase 2 4 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
MT-7117 high dose	MT-7117 high dose	phase 3	Soluble guanylate cyclase (sGC) activator	Soluble guanylate cyclase (sGC)	Cardiovascular
MT-7117 low dose	MT-7117 low dose	phase 3	Soluble guanylate cyclase (sGC) activator	Soluble guanylate cyclase (sGC)	Cardiovascular / Pulmonary Hypertension
MT-7117	MT-7117	phase 3	Soluble guanylate cyclase (sGC) activator	Soluble guanylate cyclase (sGC)	Cardiovascular

Therapeutic area mix

Cardiovascular · 2
Cardiovascular / Pulmonary Hypertension · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AstraZeneca · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Tanabe Pharma America, Inc.:

Cite this brief

Drug Landscape (2026). Tanabe Pharma America, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/tanabe-pharma-america-inc. Accessed 2026-05-16.